CEOs And The Complexities Of Outsourcing

Decisions on the strategies and implementation of drug development and manufacturing outsourcing have never been so important to the overall health and direction of both emerging and established biopharma organizations. CEOs today need to take on a higher degree of leadership in making these decisions. To outsource or not, how much, where and when, have become existential questions of survival, and keys to success (or failure). Chief Editor Louis Garguilo looks into how the C-Suite can navigate the complexities involved.